244 related articles for article (PubMed ID: 1387022)
1. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.
Ortiz J; Artigas F
Br J Pharmacol; 1992 Apr; 105(4):941-6. PubMed ID: 1387022
[TBL] [Abstract][Full Text] [Related]
2. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
[TBL] [Abstract][Full Text] [Related]
3. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
Marley E; Wozniak KM
J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine.
Buus Lassen J; Lund J; Bechgaard E; Søndergaard I
Psychopharmacology (Berl); 1979 Aug; 64(2):149-53. PubMed ID: 115034
[TBL] [Abstract][Full Text] [Related]
5. Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice.
Alvarez JC; Sanceaume M; Advenier C; Spreux-Varoquaux O
Eur Neuropsychopharmacol; 1999 Dec; 10(1):31-6. PubMed ID: 10647094
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
Andersson A; Marcusson J
Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
[TBL] [Abstract][Full Text] [Related]
7. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
[TBL] [Abstract][Full Text] [Related]
8. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
Marcusson J; Eriksson K
J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
[TBL] [Abstract][Full Text] [Related]
9. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat.
Ortiz J; Mocaër E; Artigas F
Eur J Pharmacol; 1991 Jul; 199(3):335-9. PubMed ID: 1717295
[TBL] [Abstract][Full Text] [Related]
10. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
Buczko W; De Gaetano G; Garattini S
Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
[TBL] [Abstract][Full Text] [Related]
11. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Galzin AM; Moret C; Verzier B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
[TBL] [Abstract][Full Text] [Related]
12. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
Plenge P; Mellerup ET; Honoré T; Honoré PL
J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain.
Bal N; Figueras G; Vilaró MT; Suñol C; Artigas F
Eur J Neurosci; 1997 Aug; 9(8):1728-38. PubMed ID: 9283827
[TBL] [Abstract][Full Text] [Related]
14. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
Lassen JB; Lund J; Søndergaard I
Psychopharmacology (Berl); 1980; 68(3):229-33. PubMed ID: 6446724
[No Abstract] [Full Text] [Related]
16. 5-Hydroxytryptamine uptake and imipramine binding sites in neurotumor NCB-20 cells.
Nakaki T; Roth BL; Chuang DM; Costa E
J Neurochem; 1985 Sep; 45(3):920-5. PubMed ID: 3875688
[TBL] [Abstract][Full Text] [Related]
17. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
Wood MD; Broadhurst AM; Wyllie MG
Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
[TBL] [Abstract][Full Text] [Related]
18. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
Seo KK; Kim SC; Lee MY
J Urol; 2001 Jun; 165(6 Pt 1):2110-4. PubMed ID: 11371937
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
Hashimoto K; Goromaru T
Neuropharmacology; 1991 Feb; 30(2):113-7. PubMed ID: 2030818
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Kim SC; Seo KK; Han JH; Lee MY
J Urol; 2000 Jun; 163(6):1988-91. PubMed ID: 10799244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
